Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells
ReV Up Your Vitiligo Treatment Strategies
LC-OCT Demonstrates Potential For Rapid, Effective Visualization of Inflammatory Conditions Across Skin Types
Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More